Sci. Aging Knowl. Environ., 17 July 2002
Vol. 2002, Issue 28, p. ns6
[DOI: 10.1126/sageke.2002.28.ns6]


"Gero-Tech" Sprouts, But Will It Bloom?

Scientists hope to turn academic observations into marketable interventions

R. John Davenport, and Jennifer Toy;2002/28/ns6

Abstract: Companies are betting that studies of aging will reveal new routes to life-enhancing pharmaceuticals. Antiaging pills are a distant dream, in part because testing a drug for its effect on life-span is a practical impossibility and scientists haven't yet come up with a substitute measure of aging. But research on aging might yield novel ways to treat age-related disease. Along the way, private ventures are offering new resources and a variety of experiences to academic scientists.

Citation: R. J. Davenport, J. Toy, "Gero-Tech" Sprouts, But Will It Bloom? Science's SAGE KE (17 July 2002),;2002/28/ns6

Read the Full Text

Science of Aging Knowledge Environment. ISSN 1539-6150